Search Results - Chidambaram, Nachaippan

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Efficacy and safety of LPCN 1144 in hypogonadal and eugonadal subjects for the treatment of non-alcoholic steatohepatitis (NASH) with fibrosis

    Efficacy and safety of LPCN 1144 in hypogonadal and eugonadal subjects for the treatment of non-alcoholic steatohepatitis (NASH) with fibrosis by Bruno, Benjamin, Weavil, Josh, Ogle, Jonathan, Papankorn, Kongnara, DelConte, Anthony, Chidambaram, Nachaippan, Patel, Mahesh, Albhaisi, Somaya, Sanyal, Arun

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    WED-358 - A multimodal treatment candidate for sarcopenia in men with decompensated cirrhosis: a randomized, placebo-controlled trial evaluating LPCN 1148

    WED-358 - A multimodal treatment candidate for sarcopenia in men with decompensated cirrhosis: a randomized, placebo-controlled trial evaluating LPCN 1148 by Bruno, Benjamin, Weavil, Josh, Ogle, Jonathan, Nomikos, George, DelConte, Anthony, Chidambaram, Nachaippan, Patel, Mahesh, Lai, Jennifer, Sanyal, Arun

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    FRI-466 - Efficacy and safety of LPCN 1144 in hypogonadal and eugonadal subjects for the treatment of non-alcoholic steatohepatitis (NASH) with fibrosis

    FRI-466 - Efficacy and safety of LPCN 1144 in hypogonadal and eugonadal subjects for the treatment of non-alcoholic steatohepatitis (NASH) with fibrosis by Bruno, Benjamin, Weavil, Josh, Ogle, Jonathan, Papankorn, Kongnara, DelConte, Anthony, Chidambaram, Nachaippan, Patel, Mahesh, Albhaisi, Somaya, Sanyal, Arun

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A multimodal treatment candidate for sarcopenia in men with decompensated cirrhosis: a randomized, placebo-controlled trial evaluating LPCN 1148

    A multimodal treatment candidate for sarcopenia in men with decompensated cirrhosis: a randomized, placebo-controlled trial evaluating LPCN 1148 by Bruno, Benjamin, Weavil, Josh, Ogle, Jonathan, Nomikos, George, DelConte, Anthony, Chidambaram, Nachaippan, Patel, Mahesh, Lai, Jennifer, Sanyal, Arun

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    LBO-005 Intervention with oral LPCN 1148 improves sarcopenia and hepatic encephalopathy (HE) in patients with cirrhosis: a 52-week phase 2 randomized clinical trial

    LBO-005 Intervention with oral LPCN 1148 improves sarcopenia and hepatic encephalopathy (HE) in patients with cirrhosis: a 52-week phase 2 randomized clinical trial by Bruno, Benjamin, Weavil, Josh, Ogle, Jonathan, Chidambaram, Nachaippan, Carey, Elizabeth, Danford, Christopher, Fricker, Zachary, Galati, Joseph, Lee, William M., Mantry, Parvez, Shetty, Kirti, DelConte, Anthony, Patel, Mahesh, Sanyal, Arun J., Lai, Jennifer

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    LBP-03-LPCN 1144, an Androgen Receptor Agonist Targeted for NASH, Reduces Liver Fat and Key Serum Biomarkers

    LBP-03-LPCN 1144, an Androgen Receptor Agonist Targeted for NASH, Reduces Liver Fat and Key Serum Biomarkers by Baker, Jonathan, Kim, Kilyoung, Byrne, Burke, Chidambaram, Nachaippan, Sanyal, Arun, Charlton, Michael, Patel, Mahesh

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: